Jennewein takes on Nestlé over baby formula patents
14-01-2020
BrianAJackson / iStockphoto.com
Nestlé’s Skin Health unit has been accused of infringing patents and misappropriating trade secrets relating to neurotoxin and derma filler injections.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Nestlé Skin Health, Truinject, patent infringement, trade secrets, trade dress, injections, Botox, neurotoxin, proprietary technology, training
